Salivary gland carcinoma: Towards a more personalised approach.

Abstract excerpt

Salivary Gland carcinomas (SGCs) are rare tumors accounting for less than 1% of all cancers with 21 histologically diverse subtypes. The rarity of the disease presents a challenge for clinicians to conduct large size randomized controlled trials. Surgery and radiotherapy remain the only curative treatment for localized disease, whereas treatments for recurrent and metastatic disease remain more challenging with...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Carcinoma
• Share to Mutation
• Share to Oncogenes